Navigation Links
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
Date:11/15/2012

GBI Research found that on average biobetter launches generate more revenues than their corresponding originator therapies. In some scenarios this extended to, the launch of a biobetter therapy substituting the sales from an existing originator product or biobetter therapy.

Scope

- Data and analysis on the impact of biobetter therapeutics on the major top selling biologics erythropoietin's, granulocyte-colony stimulating factors (G-CSF), interferon-?, interferon-beta, insulin and insulin analogs, human growth hormone and monoclonal and mAbs.- Pipeline analysis of biobetter therapies in major protein classes erythropoietin's, G-CSF, interferon-?, interferon-beta, insulin and insulin analogs, mAbs and TNF-?.- Key drivers and restraints that have had a significant impact on the market.- The competitive landscape of the global biobetter therapeutics market, including companies such as Celgene, Amgen, Bristol-Myers Squibb, Amylin and Dainippon Sumitomo Pharma.- Key M&A activities and licensing and co-development agreements that took place from 2010-2012 in the global Biobetters market.

Reasons to buy

- Align your product portfolio to the markets with high growth potential.- Develop business strategies by understanding the trends shaping and driving technological advancements in the field of biobetter therapies.- Identify key molecules in development being used for biobetter therapies. - Reinforce R&D pipelines by identifying common drug class biobetters in the pipeline for top selling protein classes.- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Table of Contents

1 Table of Contents1 Table of Contents 61.1 List of Tables 81.2 List of Figures 82 Introduction 93 Global Market Overview 113.1 Biobetter Therapies Already on the Market 113.1.1 Erythropoietins 123.1.2 Granulocyte-colony Stimulating Factors 143.1.3 Interferon-?, Interferon-
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. AspenBio to Present at 2012 Lazard Capital Markets Healthcare Conference
2. Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
3. Regulus to Present at the Lazard Capital Markets Healthcare Conference
4. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
5. Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
6. Sangamo BioSciences Announces Presentation At The Lazard Capital Markets Healthcare Conference
7. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
8. Kinase Inhibitors: Global Markets -- Focus on the U.S.
9. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
10. MarketsandMarkets: Global Spine Surgery Devices Market Worth $14.8 Billion by 2017
11. MarketsandMarkets: World Sensors Market in Healthcare Applications is expected to reach $13.11 billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... OR (PRWEB) October 20, 2014 Local ... participate in an investigational study of donor stem cells ... in stem cell therapy and has performed clinical stem ... this study is to determine if a single injection ... affected joints can help reduce pain and inflammation in ...
(Date:10/19/2014)... 19, 2014 The Asia-Pacific Bromine ... in Asia-Pacific with analysis and forecast of revenue. ... Pacific Bromine Market report, to get an idea ... a glimpse of the segmentation in the Asia-Pacific ... and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , ...
(Date:10/19/2014)... Orthopedic braces and support systems report defines and segments the ... The Orthopedic braces and support systems market in Asia is ... a developing CAGR of 4.4% from 2013 to 2018. , ... support systems market, to get an idea of the in-depth ... of orthopedic braces and support systems market in the same ...
(Date:10/18/2014)... October 18, 2014 The Asia-Pacific ... and segments the bio-based advanced phase change material ... revenue. , Browse through the TOC of the ... to get an idea of the in-depth analysis ... segmentation in the Asia-Pacific bio-based advanced phase change ...
Breaking Biology Technology:Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 4The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 4
... 5 Schering-Plough Corporation (NYSE: SGP ) ... by David Nicholson, Ph.D., senior vice president, Global Project ... Barclays Capital Global Healthcare Conference in Miami on Tuesday, ... is expected to talk about the company,s R&D pipeline ...
... rosacea-specific study also slated for presentation at American Academy ... NAPA, Calif., March 5 Senetek PLC (OTC Bulletin ... development of technologies that target the science of healthy ... at the American Academy of Dermatology,s 67th Annual Meeting ...
... SAN FRANCISCO, Calif., March 5 Poniard Pharmaceuticals, ... company focused on innovative oncology therapies, today announced ... discuss the Company,s fourth quarter and year-end financial ... development activities for picoplatin, the Company,s lead product ...
Cached Biology Technology:Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers 2Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers 3Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Results Conference Call on March 12 2
(Date:10/18/2014)... referred for evaluation of suspected genetic conditions, whole-exome ... percent, including detection of a number of rare ... according to a study appearing in JAMA ... with the American Society of Human Genetics annual ... coding regions of thousands of genes simultaneously using ...
(Date:10/17/2014)... German . To ... treating overdoses, doctors are often limited to supportive therapy such ... a combination of drugs involved. So what can be done ... pills? ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical ... this question. "The task was to develop an agent that ...
(Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
... a person with allergies or asthma, breathing in pollen ... inhalation by someone sensitive to their effects, these tiny ... producing uncontrollable sneezing, coughing, or extreme shortness of breath ... allergy and asthma attacks. , Scientists have long assumed ...
... of the effect of male circumcision on HIV infection, ... published in PLoS Medicine on October 25. ... new infections among heterosexual men in South Africa by ... are generally lower among African groups where circumcision is ...
... Nuclear Medicine uses PET, radiotracer to track enzyme in ... enzyme in the lungs, possibly contributing to some of ... in the September issue of the Journal of Nuclear ... the enzyme, also shows that smokers had a lower ...
Cached Biology News:New factor implicated in allergy and asthma attacks 2New factor implicated in allergy and asthma attacks 3PLoS Medicine publishes first trial of effect of male circumcision on HIV infection 2PLoS Medicine publishes first trial of effect of male circumcision on HIV infection 3Smoking damages key regulatory enzyme in the lung 2Smoking damages key regulatory enzyme in the lung 3